Population Pharmacokinetic Modelling and Simulation of Imeglimin in Type 2 Diabetes Patients to Support Dose Recommendations to Patients with Renal Impairment

MIDD

Endocrinology

Specific populations

Pharmacometrics

Metabolism

Renal diseases

Mezzalana E, Tomita Y, Hansson E, Mazuir F, Wellhagen G, Ooi QX, Kitamura A, Nemoto D, Bolze S